Why should I attend?
Register yourself and a team online now!
Become a free member of Pharma IQ's online community.
Early Bird Discount
Register and pay by 25 April 2008 and receive up to €500 off!
Special Discount
Government, Academic and non-profit discount of 50% available off the standard price
Highly-valuable insights, personal experiences
Luke Custerson, UCB Celltech
Interesting to see the same challenges and the different approaches to them
Ellen Simkiss, AstraZeneca
Broad range of speakers-relevant talks. Very good place to exchange - good for networking. Open discussion
Sylviane Komesli, Organon Ltd
Pharma IQ’s 2nd Annual Drug Discovery Automation meeting is here! Fresh from a successful November event, DDA 2008 continues to focus on how you can harness the power of automation and related technologies, for your drug discovery purposes, in the most beneficial ways.
Bringing you information to improve the success of your drug discovery, including:
- Financially attractive decision-making
- Utilising the latest innovations to stay ahead of the competition
- Learning from breakthrough methodology to boost your productivity
- Gaining insights into automation in biological related research
- Peer-to-peer discussion and idea-sharing
Who will I meet and who is speaking?
With expert speakers representing leading companies including:
Merck Serono International SA, Organon UK, Genmab B.V., Cellzome, The Netherlands Cancer Institute, GlaxoSmithKline, Merck Research Laboratories, Pfizer (UK), 7TM Pharma A/S, Boehringer Ingelheim, Lectus Therapeutics and Axxam
Click here to view the full programme
DDA 2008 will mix presentations, case studies, advances and implementations from both large and SME biopharmaceutical companies. Allowing you to compare, contrast and gain from market-wide insights at all levels, to put together strategies benefiting the unique needs of your lab.
By attending DDA 2008, you will gain from the experience of industry leaders and learn how to:
- Comprehensively assess your lab requirements to equip you with the best automation plan
- Use your automation solutions to achieve optimal results
- Successfully achieve integration
- Allow for flexibility to support a range of new activities
- Determining the most advantageous system architecture for your lab
Don't miss this event because...
Last year’s DDA meeting brought into focus, the issue of interfacing automation, and the problematic effects that can be caused by limitations in interfacing possibilities. A working group was formed to further standardisation of automation interfaces within the industry. Learn more by following this link.
Drug Discovery Automation 2008 will bring together all those concerned with automation solutions for their drug discovery labs, within the Pharmaceutical and Biotech industry
2007 Delegate Profile:
- Lab Automation Manager/Director
- R&D Director
- Senior Research Scientist
- Director of Discovery
- Laboratory Manager
|
Automation Project Leader
Head of IT Project Developments
Head of Systems Integration
Head of Laboratory Analytics
|
Past Delegates Include Representatives From:
- AstraZeneca
- Wyeth Research
- Tibotec BVBA
- LVMH Recherche
- UCB Celltech
- Merck Research Laboratories
- Genmab
- GSK
- Merz Pharma GmbH & Co. KGaA
- Grunenthal GmbH
- Cambridge Antibody Technology
|
Organon Laboratories Ltd.
Institute de Recherches SERVIER
Stem Cell Sciences
Novartis Pharma AG
Bayer
Eli Lilly
NV Organon
Johnson & Johnson Pharmaceutical
Pfizer
Bristol-Myers-Squibb
|
Equip yourself with the knowledge to gainfully automate and maintain your lab, by attending DDA 2008 - Book your place today!
If you are not yet ready to register, feel free to request a reminder nearer the time .
Conference Partners
| Session Sponsor |
Drinks Reception Sponsor |
Media Partners |
|
|
|
[ Register Now]
· [ Next: Conference Day One: Thursday, 26 June 2008 ]